Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells

References

• KostovaIPlatinum complexes as anticancer agentsRecent Patents Anti-Cancer Drug Discov200611122
   PubMed Web of Science ®Google Scholar
• KellandLThe resurgence of platinum-based cancer chemotherapyNature Rev Cancer20077857358417625587
   PubMed Web of Science ®Google Scholar
• WangDLippardSJCellular processing of platinum anticancer drugsNature Rev Drug Discov20054430732015789122
   PubMed Web of Science ®Google Scholar
• OlszewskiUHamiltonGA better platinum-based anticancer drug yet to come?Anticancer Agents Med Chem201010429330120187870
   PubMed Web of Science ®Google Scholar
• HallMDMellorHRCallaghanRHambleyTWBasis for design and development of platinum(IV) anticancer complexesJ Med Chemistry2007501534033411
   PubMed Web of Science ®Google Scholar
• HallMDAlderdenRAZhangMThe fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumoursJ Struct Biol2006155384416630726
   PubMed Web of Science ®Google Scholar
• BhargavaAVaishampayanUNSatraplatin: leading the new generation of oral platinum agentsExpert Opin Investig Drugs2009181117871797
   PubMed Web of Science ®Google Scholar
• HambleyTWBattleARDeaconGBModifying the properties of platinum(IV) complexes in order to increase biological effectivenessJ Inorg Biochem1999771–231210626347
   PubMed Web of Science ®Google Scholar
• FoltinováVŠvihálková ŠindlerováLHorváthVMechanisms of effects of platinum (II) and (IV) complexes. Comparison of cisplatin and oxaliplatin with satraplatin and LA-12, new PT(IV)-based drugsScripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae200881105116
   Google Scholar
• NakaiTAndoMOkamotoYModulation of oxidative DNA damage and DNA-crosslink formation induced by cis-diammine-tetrachloro-platinum(IV) in the presence of endogenous reductantsJ Inorg Biochem201110511521134595
   PubMed Web of Science ®Google Scholar
• CuboLHambleyTWSanz MiguelPJThe preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicityDalton Trans20114034434720936210
   PubMed Web of Science ®Google Scholar
• CarrJLTingleMDMcKeageMJSatraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitroCancer Chemother Pharmacol20065748349016172904
   PubMed Web of Science ®Google Scholar
• KonovalovaALPresnovMAZheligovskaiaNNTreshchalinaEMAntitumor effect of complex compounds of tetravalent platinumDoklady Akademii Nauk SSSR19772341223226880861
   PubMedGoogle Scholar
• PresnovMAKonovalovaALKozlovAMThe antitumor activity of oxoplatinumNeoplasma198532173834039040
   PubMed Web of Science ®Google Scholar
• NovákováOVránaOKiselevaVIBrabecVDNA interactions of antitumor platinum(IV) complexesEur J Biochem19952286166247737155
   PubMedGoogle Scholar
• OlszewskiUAchFUlspergerEIn vitro evaluation of oxoplatin: an oral platinum(IV) anticancer agentMet Based Drugs200934891619587824
   PubMedGoogle Scholar
• SchilderRJLaCretaFPPerezRPPhase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 scheduleCancer Res19945437097178306332
   PubMed Web of Science ®Google Scholar
• TraskCSilverstoneAAshCMA randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancerJ Clin Oncol199197113111372045855
   PubMed Web of Science ®Google Scholar
• ChoiSFilottoCBisanzoMReduction and anticancer activity of platinum(IV) complexesInorg Chem19983725002504
   Web of Science ®Google Scholar
• PlattsJAErmondiGCaronGMolecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexesJ Biol Inorg Chem201116336137221080205
   PubMed Web of Science ®Google Scholar
• MontañaAMBatallaCThe rational design of anticancer platinum complexes: the importance of the structure-activity relationshipCurr Med Chem200916182235226019519389
   PubMed Web of Science ®Google Scholar
• GalanskiMRecent developments in the field of anticancer platinum complexesRecent Pat Anticancer Drug Discov20061228529518221042
   PubMed Web of Science ®Google Scholar
• HarperBWKrause-HeuerAMGrantMPAdvances in platinum chemotherapeuticsChemistry2010167064707720533453
   PubMed Web of Science ®Google Scholar
• GibsonDThe mechanism of action of platinum anticancer agents: what do we really know about it?Dalton Trans200948106811068920023895
   PubMed Web of Science ®Google Scholar
• TalmanEGKidaniYMohrmannLReedijkJCan Pt(IV)-amine complexes act as ‘prodrugs’?Inorg Chim Acta1998283251255
   Web of Science ®Google Scholar
• ReithoferMRBytzekAKValiahdiSMTuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexesJ Inorg Biochem2011105465121134601
   PubMed Web of Science ®Google Scholar
• ChaneySGGibbonsGRWyrickSDPodhaskyPAn unexpected biotransformation pathway for tetrachloro-(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in the L1210 cell lineCancer Res1991519699731988140
   PubMed Web of Science ®Google Scholar
• PendyalaLWalshJRHuqMMUptake and metabolism of iproplatin in murine L1210 cellsCancer Chemother Pharmacol19892515182590997
   PubMed Web of Science ®Google Scholar
• PendyalaLArakaliAVSansonePDNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)Cancer Chemother Pharmacol1990272482502265462
   PubMed Web of Science ®Google Scholar
• McKeageMJBoxallFEJonesMHarrapKRLack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the ratCancer Res1994546296318306321
   PubMed Web of Science ®Google Scholar
• O’RourkeTJWeissGRNewPPhase I clinical trial of ormaplatin (tetraplatin, NSC 363812)Anticancer Drugs1994555205267858283
   PubMed Web of Science ®Google Scholar
• VolckovaEWeaverEBoseRNInsight into the reactive form of the anticancer agent iproplatinEur J Med Chem2008431081108417707553
   PubMed Web of Science ®Google Scholar
• EastmanAGlutathione-mediated activation of anticancer platinum(IV) complexesBiochem Pharmacol19873623417741783689445
   PubMed Web of Science ®Google Scholar
• KidoYKhokharARSiddikZHGlutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cellsBiochemical Pharmacol19944716351642
   Web of Science ®Google Scholar